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Although the mortality rate for all cancers in Japan has declined in recent years, breast cancer has been an exception because its mortality rate has tended to increase. Further, while a previous study reported that age standardized mortality rates of overall cancer and some major types of cancer have been declining, some cancers, including pancreas, breast and urinary bladder, have shown an upward trend (Qiu et al. 2009 ). Moreover, the number of breast cancer deaths has been predicted to increase, indicating an ongoing increase in the burden of this disease (Tominaga and Kuroishi 1999) .
Incidence and mortality rates are frequently used to measure the burden of various health problems, but these rates may not be suitable for measuring premature mortality in the target population. Years of life lost (YLL) and average years of life lost (AYLL), alternative health indicators, have been proposed to measure premature mortality. The former indicates how many years that life of a patient was shortened with the presence of cancer and the latter shows an average of YLL among these deceased persons (Burnet et al. 2005; Pham et al. 2009 ). By giving greater weight to deaths occurring at younger ages than to those occurring in older populations, YLL and AYLL may provide a more accurate measurement of premature deaths of any condition (Centers for Disease Control 1986; Burnet et al. 2005) . Moreover, significant increases in YLL and AYLL in the population or in specific population groups may indicate the connection of the population with the risk of premature death. Interventions which are designed to reduce the impact of this risk and to focus on the target group will be more effective (Centers for Disease Control 1986). Assessment of recent annual changes in YLL and AYLL may be therefore helpful in monitoring premature mortality in the population.
In the present study, we estimated premature mortality due to breast cancer, by examining YLL and AYLL of this disease in Japanese women during the period from 1995 to 2006.
Materials and Methods

Study population
We obtained the number of female breast cancer deaths in 
Life tables for Japan
The Ministry of Health, Labour and Welfare in Japan reports complete life tables every five years. These tables show functional data by age for death rate, survival rate, and remaining life expectancy. In the current study, we used the 1995 life tables as the beginning of the period from 1995 to 2006 to estimate YLL (Ministry of Health Labour and Welfare-Japanese Government). According to these life tables, life expectancy at birth for the year 1995 was 82.96 years in women.
Statistical analyses
We first considered actual numbers of breast cancer deaths in women for the period from 1995 to 2006. Age-standardized rate (ASR) of breast cancer mortality per 100,000 women was calculated for each year using the direct method according to the World Standard Population. Years of life lost was computed by estimating the difference between the actual age at death of a subject who died from breast cancer and the expected age at death in the 1995 year life tables. Overall YLL corresponded to the sum of the products obtained for each age group, and was expressed by the following formula:
where i = actual age at death; d i = yearly numbers of deaths; and e i = life expectancy at age i, derived from the 1995 life tables.
Both ASR and YLL were corrected for deaths of unknown age. The procedure involves simply multiplying either the summary measure based on deaths of known age (here, ASR and YLL) by T/K, where T is total number of deaths of the same type in of the same sex and K is the number occurring in persons of known age. In the present data, cases of unknown age were small, ranging from zero to three deaths. AYLL is simply an average derived by dividing total YLL by the number of breast cancer deaths.
All statistical analyses were performed using the Stata version 9.0 software package (Stata Corporation 2005) .
Results
Over more than 10 years from 1995 to 2006, the actual number of breast cancer deaths increased from 7,763 in 1995 to 11,177 in 2006 (Table 1) . Accordingly, ASR increased from 7.5/100,000 to 8.9/100,000 persons, respectively. Among all age groups, the number of breast cancer deaths was predominantly observed in women aged 50-59 years for each calendar year. In addition, this number increased annually in women aged 50 years or more.
We also observed an increase in annual YLL over this period, from 204,840.6 years in 1995 to 255,046.9 years in 2006 ( Table 2 ). In each calendar year, the proportion of YLL remained consistently the highest in the group aged 50-59 years, accounting for 32%-36% of annual YLL. In contrast, we found a decrease in AYLL of breast cancer from 26.4 years in 1995 to 22.8 years in 2006. In other words, breast cancer patients who died in 2006 lived an average 3.6 years longer than those who died in 1995.
Discussion
In the present study, we found that ASR of breast cancer mortality increased during the period from 1995 to 2006, corresponding to an increment in yearly YLL of breast cancer deaths. These findings highlight the burden of breast cancer on the life expectancy of Japanese women over the study period. However, the AYLL of this condition annually decreased, indicating that women had been died of breast cancer at later ages of life at the end of this 10-year period.
Both YLL and AYLL reflect premature mortality, indicating by how many years earlier than the expected age a person died. The YLL represents the population burden as a whole, whereas AYLL provides an average loss of expected years of life. Both indicators give greater weight to the younger women and less weight to the elderly. Ideally we would like the YLL to decrease over time. However, we observed an increase in annual YLL of this cancer, which The postponement of these deaths may be related in part to the improvements in medical health care or appropriate prevention during this period. The annual trend in YLL, which shows the burden of breast cancer in terms of lifespan, increased in relation to the increase in mortality rate. However, several interventions have nevertheless helped to decrease this loss, including implementation of screening programs, providing appropriate treatment and monitoring of risk factors (Veronesi et al. 2005; Pham et al. 2009 ). To date, mammographic screening has been considered the most effective method of reducing breast cancer mortality in many countries (Elmore et al. 2005; Kawai et al. 2009 ); however, the late introduction and insufficient coverage of these programs in Japan have led to a small number of screened subjects (Morimoto et al. 2004) . While the recent achievement of screening rates of 70-80% of the target population of women aged 40 years or over has resulted in a significant decrease in breast cancer mortality rates in Europe and the US, the 12.4% rate in Japan is too low to have reduced mortality rates (Morimoto et al. 2009 ). Resulting from controversies over the effects of mammographic screening on diagnosis in women aged less than 50 years, digital mammography in combination with computer-aid diagnosis, magnetic resonance imaging and ultrasonography have been selected as alternative methods that might improve the ability to detect early-stage disease in this group (Morimoto et al. 2009 ). YLL of breast cancer might also be affected by the influence of the absence of breastfeeding, use of hormone replacement therapy, and a family history of breast cancer in a first-degree relative (Veronesi et al. 2005 ). On these bases, women at high risk of breast cancer should be recommended for early screening.
The increase in YLL in groups aged 50 years or more indicates the need to consider the risk of premature death due to breast cancer in these women, and the need for appropriate interventions in the 50-59 years group, in whom proportion of YLL was the highest. Additionally, deaths at younger ages were also observed from 1995 to 2006, namely 2 deaths seen at 10-14 years of age and other 5 deaths at 15-19. These ages appear too young for the development of cancer, warranting further investigation.
AYLL, which shows the consequences of cancer individually rather than among all patients as a whole, indicates how many years of life in general women with breast cancer are likely to lose according to life expectancy. In recent studies in Japan, AYLL demonstrated a negative effect of breast cancer on lifespan in individual patients compared with other cancers. Stomach, liver and lung cancer in women, for instance, had AYLL of about 15-16 years, but breast cancer had AYLL of about 25 years (Pham et al. 2009 (Pham et al. , 2010 . The results from our study also showed that breast cancer patients in Japan have, however, benefited from a decline in AYLL, as indicated by a 3.6-year decrease in this variable at the end of the study period. The decline in AYLL indicates that the lifespan of these patients may have been extended due to better cancer care, such as early diagnosis and improvements in treatment (Peto et al. 2000; Mayor 2009 ). A previous study reported that the five-year survival rate of patients identified at mammographic screening was higher than that of those detected by clinical breast examination and self-detection (Kawai et al. 2009 ). Furthermore, adjuvant endocrine therapy helps prevent the reoccurrence of breast cancer, a likely consequence of the improvement in lifespan in these patients (Crivellari et al. 2003) .
In conclusion, the present study reports an increase in total numbers of annual YLL during the period between 1995 and 2006, but also reports a decrease of 3.6 years in AYLL of breast cancer deaths. Breast cancer deaths 
